ReP USP - Resultado da busca

Filtros : "Morissette, Mathieu C" Limpar

Filtros

Indexado em
Collaboration
Normalized affiliation
Non normalized affiliation
- centre de recherche de l'institut universitaire de cardiologie et de pneumologie de québec (criucpq), faculté de médecine, université laval, quebec, québec city, canada (1)
- centre de recherche de l’institut universitaire de cardiologie et de pneumologie de québec – université laval (criucpq), québec city, québec, canada (1)
- centre de recherche sur le cancer de l’université laval, université laval, québec city, québec, canada (1)
- division of hypothalamic research, department of internal medicine, university of texas southwestern medical center, dallas, texas, usa (1)
- département de biologie moléculaire, biochimie médicale et pathologie, faculté de médecine, université laval, quebec, québec city, canada (1)

Artigo de periodico
Loss of VSTM2A promotes adipocyte hypertrophy and disrupts metabolic homeostasis (2025)
Dow, Manal Al ; Secco, Blandine; Mouchiroud, Mathilde ; Rochette, Marianne ; Gilio, Gustavo Renan ; Massicard, Mickael ; Hardy, Marilou; Gélinas, Yves; Morissette, Mathieu C ; Manem, Venkata S. K. ; Laplante, Mathieu ; Festuccia, William Tadeu Lara
Source: Obesity. Unidade: ICB
Subjects: FISIOLOGIA, OBESIDADE, TECIDO ADIPOSO, ADIPOSIDADE, HOMEOSTASE, HIPERPLASIAS, LIPÍDEOS DA MEMBRANA, PROTEÍNAS DA MEMBRANA, GLICOSE, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DOW, Manal Al et al. Loss of VSTM2A promotes adipocyte hypertrophy and disrupts metabolic homeostasis. Obesity, v. 33, n. 3, p. 522-536, 2025Tradução . . Disponível em: https://doi.org/10.1002/oby.24224. Acesso em: 13 jun. 2025.
APA
Dow, M. A., Secco, B., Mouchiroud, M., Rochette, M., Gilio, G. R., Massicard, M., et al. (2025). Loss of VSTM2A promotes adipocyte hypertrophy and disrupts metabolic homeostasis. Obesity, 33( 3), 522-536. doi:10.1002/oby.24224
NLM
Dow MA, Secco B, Mouchiroud M, Rochette M, Gilio GR, Massicard M, Hardy M, Gélinas Y, Morissette MC, Manem VSK, Laplante M, Festuccia WTL. Loss of VSTM2A promotes adipocyte hypertrophy and disrupts metabolic homeostasis [Internet]. Obesity. 2025 ; 33( 3): 522-536.[citado 2025 jun. 13 ] Available from: https://doi.org/10.1002/oby.24224
Vancouver
Dow MA, Secco B, Mouchiroud M, Rochette M, Gilio GR, Massicard M, Hardy M, Gélinas Y, Morissette MC, Manem VSK, Laplante M, Festuccia WTL. Loss of VSTM2A promotes adipocyte hypertrophy and disrupts metabolic homeostasis [Internet]. Obesity. 2025 ; 33( 3): 522-536.[citado 2025 jun. 13 ] Available from: https://doi.org/10.1002/oby.24224
Artigo de periodico
The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis (2019)
Mouchiroud, Mathilde ; Camiré, Étienne; Aldow, Manal; Caron, Alexandre ; Jubinville, Éric ; Turcotte, Laurie; Kaci, Inès; Beaulieu, Marie-Josée; Roy, Christian ; Labbé, Sébastien M ; Varin, Thibault V; Gélinas, Yves; Lamothe, Jennifer; Trottier, Jocelyn; Mitchell, Patricia L ; Guénard, Frédéric ; Festuccia, William Tadeu Lara ; Joubert, Philippe ; Rose, Christopher F ; Karvellas, Constantine J ; Barbier, Oliver ; Morissette, Mathieu C ; Marette, André ; Laplante, Mathieu
Source: Molecular Metabolism. Unidade: ICB
Subjects: FISIOLOGIA, OBESIDADE, EXPRESSÃO GÊNICA, GLICOSE, HOMEOSTASE, GANHO DE PESO, CAMUNDONGOS, GORDURAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOUCHIROUD, Mathilde et al. The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis. Molecular Metabolism, v. 30, p. 184-191, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.molmet.2019.09.014. Acesso em: 13 jun. 2025.
APA
Mouchiroud, M., Camiré, É., Aldow, M., Caron, A., Jubinville, É., Turcotte, L., et al. (2019). The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis. Molecular Metabolism, 30, 184-191. doi:10.1016/j.molmet.2019.09.014
NLM
Mouchiroud M, Camiré É, Aldow M, Caron A, Jubinville É, Turcotte L, Kaci I, Beaulieu M-J, Roy C, Labbé SM, Varin TV, Gélinas Y, Lamothe J, Trottier J, Mitchell PL, Guénard F, Festuccia WTL, Joubert P, Rose CF, Karvellas CJ, Barbier O, Morissette MC, Marette A, Laplante M. The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis [Internet]. Molecular Metabolism. 2019 ; 30 184-191.[citado 2025 jun. 13 ] Available from: https://doi.org/10.1016/j.molmet.2019.09.014
Vancouver
Mouchiroud M, Camiré É, Aldow M, Caron A, Jubinville É, Turcotte L, Kaci I, Beaulieu M-J, Roy C, Labbé SM, Varin TV, Gélinas Y, Lamothe J, Trottier J, Mitchell PL, Guénard F, Festuccia WTL, Joubert P, Rose CF, Karvellas CJ, Barbier O, Morissette MC, Marette A, Laplante M. The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis [Internet]. Molecular Metabolism. 2019 ; 30 184-191.[citado 2025 jun. 13 ] Available from: https://doi.org/10.1016/j.molmet.2019.09.014

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2025